ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

China flag China · Delayed Price · Currency is CNY
39.82
+1.11 (2.87%)
Apr 29, 2026, 3:04 PM CST
1.07%
Market Cap 17.38B
Revenue (ttm) 940.78M
Net Income (ttm) 199.99M
Shares Out 449.03M
EPS (ttm) 0.44
PE Ratio 87.44
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 24,924,686
Average Volume 21,052,996
Open 35.17
Previous Close 38.71
Day's Range 35.17 - 40.02
52-Week Range 29.31 - 81.48
Beta 0.53
RSI 66.85
Earnings Date Apr 24, 2026

About SHE:300723

ApicHope Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pharmaceutical drugs in China. The company offers pediatric medicines, such as fuganlin and yiqi jianpi oral liquids, carboxymestrine oral solutions, and xiao’er kechuanling oral liquid products; and clindamycin palmitate hydrochloride dispersible tablets, acetylkitasamycin for suspension, qinxiangqingjie oral liquids, epinastine hydrochloride granules, clindamycin palmitate hydrochloride granules, clindamyxin hydrochloride for injection, clind... [Read more]

Sector Healthcare
Founded 2002
Employees 1,484
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300723
Full Company Profile

Financial Performance

In 2025, SHE:300723's revenue was 932.27 million, a decrease of -35.72% compared to the previous year's 1.45 billion. Losses were -337.79 million, -37.45% less than in 2024.

Financial Statements

News

There is no news available yet.